Table 2. DNA methylation at birth and general psychopathology: meta-analytic associations with p < 1 × 10−5.
CpG | Gene | Chr | Position | n | B | SE | p | Direction | I2 | Heterogeneity p-value |
---|---|---|---|---|---|---|---|---|---|---|
cg02084087 | TNFRSF25 | chr1 | 6526049 | 2175 | 4.31 | 0.95 | 5.54 × 10−6 | ++++ | 46.2 | 0.13 |
cg11777523 | GPR148 | chr2 | 131485418 | 2019 | 9.26 | 2.07 | 7.80 × 10−6 | +?++ | 23.6 | 0.27 |
cg14358879 | SLC8A3 | chr14 | 70655920 | 2174 | -7.82 | 1.75 | 8.20 × 10−6 | ---- | 33.7 | 0.21 |
cg09437808 | - | chr5 | 176107069 | 2177 | 2.46 | 0.55 | 8.96 × 10−6 | ++++ | 0 | 0.47 |
Chr chromosome, n number of participants, SE standard error, Direction direction of the effect per study (ALSPAC, DCHS, GENR, INMA) in alphabetical order (+ = positive direction, − = negative direction, ? = not present); I2 heterogeneity statistic reflecting the variation attributable to heterogeneity across studies (high values suggest high heterogeneity)
Effect estimates (B) represent the SD increase in GPF for each increase of 100% in DNAm.